Literature DB >> 9811757

HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.

C E Mackewicz1, M R Garovoy, J A Levy.   

Abstract

CD8(+) T cells from human immunodeficiency virus (HIV)-infected individuals can suppress HIV replication in cultured CD4(+) cells by a noncytotoxic mechanism. Efficient suppression of HIV replication (>90% reduction) does not require HLA class I or class II histocompatibility between the effector CD8(+) T cells and the infected target CD4(+) T cells. However, maximal control of HIV production occurs when the CD8(+) effector cells and CD4(+) target cells are syngeneic. In some cases, more than 20-fold fewer syngeneic CD8(+) T cells were required to achieve the same degree of HIV inhibition as HLA-mismatched CD8(+) T cells. The increased antiviral activity seen in the syngeneic setting did not map exclusively to either the HLA class I or class II locus. These findings suggest that genetic compatibility (potentially, but not necessarily, at the HLA class I and class II loci) regulates CD8(+) T-cell noncytotoxic antiviral activity against infected CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811757      PMCID: PMC110558     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.

Authors:  C Mackewicz; J A Levy
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

2.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

3.  CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses.

Authors:  C M Walker; G A Thomson-Honnebier; F C Hsueh; A L Erickson; L Z Pan; J A Levy
Journal:  Cell Immunol       Date:  1991-10-15       Impact factor: 4.868

4.  Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees.

Authors:  B A Castro; C M Walker; J W Eichberg; J A Levy
Journal:  Cell Immunol       Date:  1991-01       Impact factor: 4.868

5.  Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys.

Authors:  J D Powell; T Yehuda-Cohen; F Villinger; H M McClure; K W Sell; A Ahmed-Ansari
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

6.  Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.

Authors:  A L Kinter; S M Bende; E C Hardy; R Jackson; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

8.  CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.

Authors:  C E Mackewicz; D J Blackbourn; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture.

Authors:  L D Wiviott; C M Walker; J A Levy
Journal:  Cell Immunol       Date:  1990-07       Impact factor: 4.868

10.  Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.

Authors:  J F Toso; C H Chen; J R Mohr; L Piglia; C Oei; G Ferrari; M L Greenberg; K J Weinhold
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  17 in total

1.  Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.

Authors:  T W Chun; J S Justement; S Moir; C W Hallahan; L A Ehler; S Liu; M McLaughlin; M Dybul; J M Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

2.  Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease.

Authors:  R Salerno-Gonçalves; W Lu; J M Andrieu
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

4.  Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Authors:  M Scott Killian; Fernando Teque; Ramu Sudhagoni
Journal:  Immunogenetics       Date:  2017-07-22       Impact factor: 2.846

5.  The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.

Authors:  Carl E Mackewicz; Charles S Craik; Jay A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

6.  Differential gene expression in CD8(+) cells from HIV-1-infected subjects showing suppression of HIV replication.

Authors:  Beatriz Martinez-Mariño; Hillary Foster; Yanling Hao; Jay A Levy
Journal:  Virology       Date:  2007-01-22       Impact factor: 3.616

7.  Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

Authors:  M Scott Killian; Carl Johnson; Fernando Teque; Sue Fujimura; Jay A Levy
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

8.  Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons.

Authors:  Steven R Fauce; Otto O Yang; Rita B Effros
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

9.  CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

Authors:  M Scott Killian; Jeremy Roop; Sharon Ng; Frederick M Hecht; Jay A Levy
Journal:  J Clin Immunol       Date:  2009-02-03       Impact factor: 8.317

10.  Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission.

Authors:  Carey Farquhar; Sarah Rowland-Jones; Dorothy Mbori-Ngacha; Mary Redman; Barbara Lohman; Jennifer Slyker; Phelgona Otieno; Elizabeth Obimbo; Timothy Rostron; James Ochieng; Julius Oyugi; Rose Bosire; Grace John-Stewart
Journal:  AIDS Res Hum Retroviruses       Date:  2004-07       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.